Vbx-026

N/A

Report date: 2025/02/06 10:15:55

Base Information

Drug NameVbx-026

Drug Alias NameVbx-026

ClassificationVaccines > Application > Therapeutic vaccine

Mechanisms of ActionTelomerase reverse transcriptase inhibitorsReceptor protein-tyrosine kinase erbB-2 antagonistsCarcinoembryonic antigen inhibitors +[4]

TargetsTelomerase reverse transcriptaseReceptor protein-tyrosine kinase erbB-2Carcinoembryonic antigen +[4]

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesVaxon Biotech

China Registration ClassN/A

Develop Information

Active CompaniesVaxon Biotech

Inactive CompaniesN/A

Active IndicationsNeoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A